Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1851449rdf:typepubmed:Citationlld:pubmed
pubmed-article:1851449lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C0007776lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C0022655lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C0001613lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C0228174lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C0034785lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:1851449lifeskim:mentionsumls-concept:C0682770lld:lifeskim
pubmed-article:1851449pubmed:issue2lld:pubmed
pubmed-article:1851449pubmed:dateCreated1991-6-19lld:pubmed
pubmed-article:1851449pubmed:abstractTextThe interaction between alpha 2- and beta-adrenergic receptors was investigated in rat cerebral cortical membranes. Clonidine inhibition of [3H]dihydroalprenolol ([3H]DHA) binding resulted in biphasic competition curves with a mean Hill coefficient of 0.45. The addition of 1 microM yohimbine caused a rightward shift of the first portion of the clonidine inhibition curve. In the presence of 1 microM clonidine, the maximum concentration which did not inhibit [3H]DHA binding, inhibition curves of [3H]DHA binding by isoproterenol shifted to the right. A mean Hill coefficient increased from a control value of 0.63 to 0.76. Computer modeling analysis revealed that 1 microM clonidine decreased a beta-adrenergic high-affinity state from 28% to 13%. However, the addition of 1 microM yohimbine completely prevented the clonidine-induced reduction in the beta-adrenergic high-affinity state. In the presence of 200 microM GTP, the effect of clonidine was not observed. In addition, Kd and Bmax values for [3H]p-aminoclonidine ([3H]PAC) binding were not significantly changed by the addition of 100 nM isoproterenol, the maximum concentration which did not inhibit [3H]PAC binding. Moreover, isoproterenol inhibition of [3H]PAC binding resulted in steep competition curves with a mean Hill coefficient of 0.97. The addition of 1 microM alprenolol did not affect the isoproterenol inhibition curve. These data demonstrated that clonidine caused a decrease in agonist and antagonist affinity for beta-adrenergic receptors, while isoproterenol did not modulate the binding characteristics of alpha 2-adrenergic receptors. Furthermore, these results suggest that regulation between alpha 2- and beta-adrenergic receptors is not bidirectional, but is instead unidirectional from alpha 2-adrenergic receptors to beta-adrenergic receptors.lld:pubmed
pubmed-article:1851449pubmed:languageenglld:pubmed
pubmed-article:1851449pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:citationSubsetIMlld:pubmed
pubmed-article:1851449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851449pubmed:statusMEDLINElld:pubmed
pubmed-article:1851449pubmed:monthMarlld:pubmed
pubmed-article:1851449pubmed:issn0006-8993lld:pubmed
pubmed-article:1851449pubmed:authorpubmed-author:NakamuraTTlld:pubmed
pubmed-article:1851449pubmed:authorpubmed-author:NomuraJJlld:pubmed
pubmed-article:1851449pubmed:authorpubmed-author:TsujimuraRRlld:pubmed
pubmed-article:1851449pubmed:issnTypePrintlld:pubmed
pubmed-article:1851449pubmed:day1lld:pubmed
pubmed-article:1851449pubmed:volume542lld:pubmed
pubmed-article:1851449pubmed:ownerNLMlld:pubmed
pubmed-article:1851449pubmed:authorsCompleteYlld:pubmed
pubmed-article:1851449pubmed:pagination181-6lld:pubmed
pubmed-article:1851449pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:meshHeadingpubmed-meshheading:1851449-...lld:pubmed
pubmed-article:1851449pubmed:year1991lld:pubmed
pubmed-article:1851449pubmed:articleTitleInteraction between alpha 2- and beta-adrenergic receptors in rat cerebral cortical membranes: clonidine-induced reduction in agonist and antagonist affinity for beta-adrenergic receptors.lld:pubmed
pubmed-article:1851449pubmed:affiliationDepartment of Psychiatry, Mie University School of Medicine, Japan.lld:pubmed
pubmed-article:1851449pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1851449lld:pubmed